NCT06357897View on ClinicalTrials.gov

The Efficacy and Palatability of Developed Polyethylene Glycol-based Formula for Children With Functional Constipation

NANot yet recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Functional Constipation
Interventions
DRUG

Local PEG4000

PEG-Chula is developed from PEG 4000 used at King Chulalongkorn Memorial Hospital with added sweetener and flavours. Children will be given PEG-Chula at a dose of 0.5 - 1 g/kg/day.

DRUG

Commercial PEG4000

For commercial PEG, We use Forlax as the control group. Children will be given Forlax at a dose of 0.5 - 1 g/kg/day.

Trial Locations (1)

10330

Faculty of Medicine, Chulalongkorn University, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT06357897 - The Efficacy and Palatability of Developed Polyethylene Glycol-based Formula for Children With Functional Constipation | Biotech Hunter | Biotech Hunter